{"gene":"FGB","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1984,"finding":"Fibrinogen is a hexameric glycoprotein composed of pairs of three chains (Aα, Bβ, and γ); thrombin cleaves fibrinogen to form insoluble fibrin polymer, establishing the fundamental mechanism of fibrin clot formation.","method":"Biochemical characterization, covalent structure analysis","journal":"Annual review of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — foundational biochemical reconstitution and structural work, replicated across decades","pmids":["6383194"],"is_preprint":false},{"year":1980,"finding":"Synthetic peptides corresponding to the N-terminal sequences released from fibrinogen by thrombin (fibrinopeptides) bind to fibrinogen and prevent fibrin polymerization, defining the knob-hole polymerization mechanism involving the β-chain N-terminus.","method":"In vitro peptide binding assay, inhibition of fibrin polymerization","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro reconstitution with defined peptides, foundational mechanistic study","pmids":["7356959"],"is_preprint":false},{"year":1983,"finding":"Complete covalent structure of fibrinogen determined, including the primary sequence of the Bβ chain encoded by FGB, establishing the disulfide bonding pattern and chain organization of the hexameric molecule.","method":"Protein sequencing, covalent structure determination","journal":"Annals of the New York Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1 — direct protein sequencing and structural determination, foundational study","pmids":["6575689"],"is_preprint":false},{"year":1993,"finding":"Fibrinogen mediates leukocyte adhesion to vascular endothelium through binding to ICAM-1 on endothelial cells, bridging leukocytes and endothelial cells in an ICAM-1-dependent adhesion pathway.","method":"Affinity chromatography purification, genetically engineered transfectants, direct binding studies to recombinant ICAM-1, cell adhesion assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including affinity purification, recombinant protein binding, and functional adhesion assays in a single study","pmids":["8100742"],"is_preprint":false},{"year":1997,"finding":"Crystal structure of fragment D from human fibrinogen determined at 2.9 Å resolution, revealing a coiled-coil region and two homologous globular domains (β and γ nodules) oriented at ~130° to each other; the double-D structure from crosslinked fibrin solved with a Gly-Pro-Arg-Pro peptide ligand defines the donor polymerization site.","method":"X-ray crystallography","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional peptide ligand validation","pmids":["9333233"],"is_preprint":false},{"year":1996,"finding":"Hyperglycemia stimulates IL-6 and TNF-α production by human peripheral blood monocytes, and conditioned media from these monocytes increases β-fibrinogen (FGB) mRNA levels in HepG2 hepatocytes, establishing a TNF→IL-6→FGB transcriptional induction axis.","method":"RT-PCR, ELISA, conditioned medium transfer to HepG2 cells, anti-TNF antibody blockade","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (RT-PCR, ELISA, antibody blocking) in a single lab establishing the cytokine-FGB induction pathway","pmids":["8666148"],"is_preprint":false},{"year":2009,"finding":"Crystal structure of intact human fibrinogen determined at ~3.3 Å resolution, revealing the full hexameric architecture including the coiled-coil regions, D and E nodules, the β-chain carbohydrate groups with 11 sugar residues, and a novel antiparallel arrangement of β chains.","method":"X-ray crystallography","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure of intact human fibrinogen","pmids":["19296670"],"is_preprint":false},{"year":2009,"finding":"A deep intronic point mutation in FGB (c.115-600A>G) creates a consensus heptad motif recognized by SF2/ASF splicing factor, causing inclusion of a 50-bp cryptic exon and truncation of the Bβ chain, preventing fibrinogen synthesis; antisense morpholino oligonucleotides blocking the protein-RNA interaction restored normal splicing (~90% at 10 µM).","method":"Minigene splicing assay, site-directed mutagenesis of enhancer motif, antisense oligonucleotide treatment in transfected cells, RT-PCR","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution with mutagenesis and functional rescue by antisense oligonucleotides, multiple orthogonal methods","pmids":["18853456"],"is_preprint":false},{"year":2003,"finding":"Expression of the FGB nonsense mutant W467X in combination with wild-type FGA and FGG showed that fibrinogen molecules containing the truncated Bβ chain are not secreted, confirming that the Bβ chain C-terminal region is required for fibrinogen secretion.","method":"Recombinant expression of mutant FGB cDNA with wild-type FGA and FGG in cell lines, secretion assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — functional expression system demonstrating secretion defect, single lab","pmids":["12511408"],"is_preprint":false},{"year":2003,"finding":"A missense mutation in FGB (G444S) allows fibrinogen chain assembly but prevents secretion, demonstrating that the C-terminal β-nodule region is critical for intracellular fibrinogen assembly and secretion rather than chain synthesis.","method":"Recombinant co-expression of mutant FGB with wild-type FGA and FGG, secretion assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — functional expression dissecting assembly vs. secretion steps, single lab","pmids":["12893758"],"is_preprint":false},{"year":2011,"finding":"A missense mutation at FGB Bβ41 (Tyr→Asn, fibrinogen Caracas VIII) impairs the fibrin polymerization process—prolonging lag time, altering clot structure (thicker fibers, larger pores, reduced viscoelasticity), and reducing fibrin interaction with endothelial cells—demonstrating the functional importance of the amino-terminal end of the β chain in polymerization and clot organization.","method":"Plasma polymerization assay, permeation studies, scanning electron microscopy, confocal laser microscopy, viscoelastic property measurement","journal":"Thrombosis and haemostasis","confidence":"Medium","confidence_rationale":"Tier 1-2 — multiple functional assays on patient plasma with defined mutation, single lab","pmids":["21301788"],"is_preprint":false},{"year":2013,"finding":"A novel frameshift insertion in FGB exon 2 (GTTT insertion between nucleotides 2833-2834) causes impaired intracellular fibrinogen assembly (abnormal high-molecular-weight molecules in cells) and prevents fibrinogen secretion, as shown by transfection of COS-7 cells with mutant constructs.","method":"Western blot, ELISA of cell lysates and culture media, transfection of COS-7 cells with wild-type and mutant fibrinogen constructs","journal":"Zhonghua xue ye xue za zhi","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based functional reconstitution demonstrating assembly and secretion defect, single lab","pmids":["24103871"],"is_preprint":false},{"year":2010,"finding":"An FGB IVS6 deletion of 4 nucleotides causes aberrant mRNA splicing with inclusion of introns 6 and 7, demonstrated by RT-PCR of minigene constructs transfected in CHO cells; the aberrant mRNA is predicted to undergo nonsense-mediated decay, causing hypofibrinogenemia.","method":"Minigene transfection in CHO cells, RT-PCR, agarose gel electrophoresis, nucleotide sequencing","journal":"Clinica chimica acta","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based minigene splicing assay with sequencing confirmation, single lab","pmids":["20580695"],"is_preprint":false},{"year":2019,"finding":"SIRT1 represses FGB expression in renal cell carcinoma by deacetylating STAT3, leading to STAT3 destabilization and degradation; STAT3 was identified as a direct transcriptional activator of FGB by luciferase reporter assay, and FGB overexpression rescued the anti-proliferative effect of SIRT1, establishing a SIRT1→STAT3→FGB axis.","method":"Luciferase reporter assay, co-immunoprecipitation, Western blot, stable transfection, in vitro and in vivo proliferation assays","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (luciferase, Co-IP, rescue experiment), single lab","pmids":["31201813"],"is_preprint":false},{"year":2020,"finding":"A heterozygous nonsense mutation FGB Bβ p.Trp474Ter results in truncated Bβ chains predicted to be retained inside hepatocytes (not secreted), causing quantitative hypofibrinogenemia; turbidity analyses showed reduced fibrin polymerization and altered fibrin fiber thickness consistent with reduced fibrinogen concentration.","method":"Protein modelling, fibrin polymerization turbidity analysis, scanning electron microscopy, coagulation functional analysis","journal":"Biomedicines","confidence":"Medium","confidence_rationale":"Tier 3 — functional assays and structural modelling, secretion inference from modelling rather than direct experiment","pmids":["33322159"],"is_preprint":false},{"year":2020,"finding":"A compound heterozygous FGB 35-bp deletion causes aberrant splicing products leading to nonsense-mediated mRNA decay (quantitative defect), while the second allele carrying BβN170K produces fibrinogen that is secreted normally but causes delayed lateral aggregation in fibrin polymerization (qualitative defect), demonstrated by minigene assay and recombinant expression in CHO cells.","method":"Minigene transfection in CHO cells, RT-PCR, Western blot, recombinant variant fibrinogen expression, thrombin-catalyzed fibrin polymerization assay","journal":"Thrombosis research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (minigene, recombinant expression, functional polymerization assay) establishing both splicing and functional defects, single lab","pmids":["32871307"],"is_preprint":false},{"year":2022,"finding":"Four FGB missense/nonsense variants (BβY416C, BβA68S, BβY345*, BβW403*) all alter fibrin polymerization (reduced maximal absorbance); BβA68S impairs fibrinopeptide B release; BβY416C and BβW403* alter plasmin-induced fibrin degradation kinetics; fiber morphology differs significantly across variants by scanning electron microscopy.","method":"Fibrin polymerization turbidity assay, reverse-phase HPLC fibrinopeptide cleavage assay, plasmin degradation assay, scanning electron microscopy, homology modelling","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1-2 — multiple orthogonal functional assays per variant, single lab","pmids":["35054908"],"is_preprint":false},{"year":2022,"finding":"miR-139-5p directly targets FGB mRNA; overexpression of miR-139-5p or silencing of FGB inhibits human brain microvascular endothelial cell (HBMEC) proliferation and tube formation and suppresses α-SMA and CXCR4 levels; rescue experiment confirmed miR-139-5p acts through FGB to regulate angiogenesis.","method":"miRNA target validation, shRNA knockdown, cell proliferation assay, tube formation assay, Western blot, rescue experiment","journal":"Journal of healthcare engineering","confidence":"Low","confidence_rationale":"Tier 3 — functional cellular assays with rescue, but single lab and target validation method not explicitly described as luciferase","pmids":["35469231"],"is_preprint":false},{"year":2022,"finding":"miR-877-5p directly regulates FGB; FGB silencing inhibits breast cancer cell proliferation and invasion, reduces tumor growth in vivo, and reverses epithelial-mesenchymal transition (reducing N-cadherin and vimentin while increasing E-cadherin).","method":"RT-qPCR, immunohistochemistry, CCK-8 proliferation assay, transwell invasion assay, flow cytometry, Western blot, xenograft tumor model","journal":"Disease markers","confidence":"Low","confidence_rationale":"Tier 3 — functional knockdown with phenotypic readout but no direct molecular mechanism of FGB action defined, single lab","pmids":["36438895"],"is_preprint":false},{"year":2005,"finding":"FGG haplotype H2 homozygosity reduces fibrinogen γ' levels and increases deep venous thrombosis risk ~2.4-fold; fibrinogen γ' contains a unique high-affinity non-substrate thrombin-binding site critical for antithrombin activity during fibrin formation (antithrombin 1), linking fibrinogen γ-chain variants to thrombin regulation.","method":"Haplotype-tagging SNP analysis, fibrinogen γ' level measurement, multivariate analysis in a population-based case-control study (Leiden Thrombophilia Study)","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 3 — large population study with functional fibrinogen measurement; the antithrombin 1 mechanism is biochemically established in earlier literature cited herein","pmids":["16144795"],"is_preprint":false}],"current_model":"FGB encodes the fibrinogen Bβ chain, which is the rate-limiting chain in hepatic assembly of the hexameric fibrinogen molecule (Aα₂Bβ₂γ₂); thrombin cleaves fibrinopeptide B from the Bβ N-terminus to expose polymerization knobs that drive fibrin polymer formation, the Bβ C-terminal β-nodule domain is essential for intracellular assembly and secretion of fibrinogen (missense and nonsense mutations in this domain impair secretion without preventing chain synthesis), FGB transcription is regulated by a SIRT1→STAT3 deacetylation axis, and the γ' isoform of fibrinogen provides a high-affinity non-substrate thrombin-binding site that mediates antithrombin 1 activity, while fibrinogen as a whole bridges leukocytes to endothelium via ICAM-1."},"narrative":{"teleology":[{"year":1980,"claim":"Defining the molecular mechanism of fibrin polymerization: synthetic peptides mimicking thrombin-released fibrinopeptides bound fibrinogen and blocked polymerization, establishing that the Bβ N-terminus exposes a polymerization knob upon cleavage.","evidence":"In vitro peptide binding and polymerization inhibition assays","pmids":["7356959"],"confidence":"High","gaps":["Structural basis of knob-hole interaction was not yet resolved","Relative contribution of fibrinopeptide A vs. B cleavage to polymerization kinetics was unclear"]},{"year":1984,"claim":"The complete covalent structure and chain organization of fibrinogen (Aα₂Bβ₂γ₂) were established, defining the hexameric architecture and disulfide bonding pattern that frames all subsequent structure–function studies of the Bβ chain.","evidence":"Protein sequencing and biochemical characterization","pmids":["6383194","6575689"],"confidence":"High","gaps":["Three-dimensional atomic structure was still unknown","Chain-specific contributions to assembly and secretion were not dissected"]},{"year":1993,"claim":"Fibrinogen was shown to function beyond coagulation as an adhesion bridge between leukocytes and endothelial ICAM-1, establishing a non-hemostatic role in vascular inflammation.","evidence":"Affinity chromatography, recombinant ICAM-1 binding studies, and cell adhesion assays using genetically engineered transfectants","pmids":["8100742"],"confidence":"High","gaps":["Which fibrinogen chain or domain directly contacts ICAM-1 was not mapped","In vivo relevance of fibrinogen-ICAM-1 bridging in inflammatory disease models was not tested"]},{"year":1996,"claim":"Hyperglycemia-induced monocyte cytokine release was linked to hepatic FGB transcriptional upregulation via a TNF→IL-6 axis, explaining elevated fibrinogen in diabetic patients.","evidence":"RT-PCR of FGB mRNA in HepG2 cells treated with conditioned media, ELISA, anti-TNF antibody blocking","pmids":["8666148"],"confidence":"Medium","gaps":["Direct promoter elements mediating IL-6 responsiveness of FGB were not mapped in this study","Whether this pathway operates identically in primary hepatocytes was not shown"]},{"year":1997,"claim":"The crystal structure of fibrinogen fragment D revealed the three-dimensional architecture of the β- and γ-nodules and defined the structural basis of knob-hole polymerization at atomic resolution.","evidence":"X-ray crystallography at 2.9 Å with GPRP peptide ligand","pmids":["9333233"],"confidence":"High","gaps":["Full-length fibrinogen structure including the central E nodule was still missing","Structural consequences of disease-causing Bβ mutations were not modeled"]},{"year":2003,"claim":"Reconstitution experiments with truncated and missense Bβ variants (W467X, G444S) demonstrated that the C-terminal β-nodule is dispensable for chain synthesis but essential for fibrinogen secretion, separating the assembly and secretion steps mechanistically.","evidence":"Recombinant co-expression of mutant FGB with wild-type FGA/FGG in mammalian cell lines, secretion assays","pmids":["12511408","12893758"],"confidence":"Medium","gaps":["Whether the secretion defect arises from ER quality control or Golgi-level retention was not resolved","Structural basis of why the β-nodule is required for secretion was not defined"]},{"year":2009,"claim":"The full-length fibrinogen crystal structure completed the atomic picture of the hexamer, revealing a novel antiparallel Bβ chain arrangement and carbohydrate organization, while a deep intronic FGB mutation was shown to cause cryptic exon inclusion rescuable by antisense oligonucleotides.","evidence":"X-ray crystallography at ~3.3 Å (intact fibrinogen); minigene splicing assays with antisense morpholino rescue","pmids":["19296670","18853456"],"confidence":"High","gaps":["Therapeutic applicability of antisense rescue in vivo was not tested","Dynamic conformational changes during polymerization were not captured"]},{"year":2011,"claim":"A natural Bβ Tyr41Asn variant (Caracas VIII) prolonged polymerization lag time, altered clot fiber thickness and pore size, and reduced viscoelasticity, quantitatively demonstrating the functional importance of the Bβ N-terminal region in clot architecture.","evidence":"Patient plasma polymerization assays, permeation studies, scanning electron microscopy, viscoelastic measurements","pmids":["21301788"],"confidence":"Medium","gaps":["Whether altered clot structure translates to bleeding risk in vivo was not demonstrated","The precise structural interaction disrupted by Tyr41Asn was not defined at atomic resolution"]},{"year":2019,"claim":"STAT3 was identified as a direct transcriptional activator of FGB, and SIRT1-mediated deacetylation of STAT3 destabilizes it, repressing FGB expression — establishing an epigenetic regulatory axis for FGB transcription outside the classic acute-phase response.","evidence":"Luciferase reporter assay, co-immunoprecipitation, FGB overexpression rescue of SIRT1 anti-proliferative effect in renal carcinoma cells","pmids":["31201813"],"confidence":"Medium","gaps":["Whether the SIRT1–STAT3–FGB axis operates in hepatocytes (the physiological source of fibrinogen) was not tested","Direct STAT3 binding to the FGB promoter was shown by reporter but not by ChIP"]},{"year":2022,"claim":"Systematic functional characterization of multiple FGB missense and nonsense variants showed that individual mutations differentially affect fibrinopeptide B release, polymerization kinetics, fiber morphology, and plasmin-mediated fibrinolysis, revealing residue-specific contributions across distinct phases of clot formation and resolution.","evidence":"Turbidity polymerization assays, HPLC fibrinopeptide cleavage, plasmin degradation kinetics, scanning electron microscopy","pmids":["35054908","32871307"],"confidence":"Medium","gaps":["Genotype–phenotype correlation with clinical bleeding severity is lacking for most variants","Structural modeling has not been validated by crystal structures of variant fibrinogens"]},{"year":null,"claim":"Key unresolved questions include the structural basis of β-nodule-dependent ER quality control during fibrinogen secretion, the in vivo contribution of the fibrinogen–ICAM-1 interaction to inflammatory disease, and whether the SIRT1–STAT3–FGB transcriptional axis operates in primary hepatocytes.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural or cryo-EM data showing how the β-nodule is recognized by ER chaperones","No genetic model isolating fibrinogen-ICAM-1 binding from coagulation function in vivo","Comprehensive genotype–phenotype map for FGB variants and clinical outcomes is absent"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2,6]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[3]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,4,6]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[8,9,11]}],"pathway":[{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[0,1,4,10,16]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[8,9,11]}],"complexes":["Fibrinogen (Aα₂Bβ₂γ₂ hexamer)"],"partners":["FGA","FGG","ICAM1","STAT3"],"other_free_text":[]},"mechanistic_narrative":"FGB encodes the fibrinogen Bβ chain, one of three polypeptide chains that assemble into the hexameric fibrinogen molecule (Aα₂Bβ₂γ₂) essential for blood coagulation and fibrin clot formation [PMID:6383194, PMID:6575689]. Thrombin cleavage of fibrinopeptide B from the Bβ N-terminus exposes polymerization knobs that drive fibrin lateral aggregation through a knob-hole mechanism, and mutations at this site (e.g., Bβ Tyr41Asn, Bβ A68S) impair polymerization kinetics and clot architecture [PMID:7356959, PMID:21301788, PMID:35054908]. The C-terminal β-nodule is required for intracellular fibrinogen assembly and secretion: nonsense and missense mutations in this domain (W467X, G444S, W474X) permit chain synthesis but block secretion, causing congenital hypo- or afibrinogenemia [PMID:12511408, PMID:12893758]. Beyond hemostasis, fibrinogen bridges leukocytes to vascular endothelium through ICAM-1 binding, and FGB transcription is regulated by an IL-6/STAT3 axis that is modulated by SIRT1-mediated STAT3 deacetylation [PMID:8100742, PMID:8666148, PMID:31201813]."},"prefetch_data":{"uniprot":{"accession":"P02675","full_name":"Fibrinogen beta chain","aliases":[],"length_aa":491,"mass_kda":55.9,"function":"Cleaved by the protease thrombin to yield monomers which, together with fibrinogen alpha (FGA) and fibrinogen gamma (FGG), polymerize to form an insoluble fibrin matrix. Fibrin has a major function in hemostasis as one of the primary components of blood clots. In addition, functions during the early stages of wound repair to stabilize the lesion and guide cell migration during re-epithelialization. Was originally thought to be essential for platelet aggregation, based on in vitro studies using anticoagulated blood. However subsequent studies have shown that it is not absolutely required for thrombus formation in vivo. Enhances expression of SELP in activated platelets. Maternal fibrinogen is essential for successful pregnancy. Fibrin deposition is also associated with infection, where it protects against IFNG-mediated hemorrhage. May also facilitate the antibacterial immune response via both innate and T-cell mediated pathways","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P02675/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FGB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FGB","total_profiled":1310},"omim":[{"mim_id":"616004","title":"DYSFIBRINOGENEMIA, CONGENITAL","url":"https://www.omim.org/entry/616004"},{"mim_id":"614390","title":"PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2","url":"https://www.omim.org/entry/614390"},{"mim_id":"614057","title":"MICRO RNA 409; MIR409","url":"https://www.omim.org/entry/614057"},{"mim_id":"605776","title":"FIBRINOGEN-LIKE 1; FGL1","url":"https://www.omim.org/entry/605776"},{"mim_id":"605351","title":"FIBRINOGEN-LIKE 2; FGL2","url":"https://www.omim.org/entry/605351"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Endoplasmic reticulum","reliability":"Enhanced"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"liver","ntpm":16764.8}],"url":"https://www.proteinatlas.org/search/FGB"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P02675","domains":[{"cath_id":"3.90.215.10","chopping":"240-485","consensus_level":"high","plddt":96.9833,"start":240,"end":485},{"cath_id":"1.20.5","chopping":"149-226","consensus_level":"medium","plddt":95.5323,"start":149,"end":226}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02675","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02675-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02675-F1-predicted_aligned_error_v6.png","plddt_mean":84.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FGB","jax_strain_url":"https://www.jax.org/strain/search?query=FGB"},"sequence":{"accession":"P02675","fasta_url":"https://rest.uniprot.org/uniprotkb/P02675.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02675/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02675"}},"corpus_meta":[{"pmid":"32610551","id":"PMC_32610551","title":"Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32610551","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18853456","id":"PMC_18853456","title":"A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.","date":"2009","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18853456","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12511408","id":"PMC_12511408","title":"Prenatal diagnosis for congenital afibrinogenemia caused by a novel nonsense mutation in the FGB gene in a Palestinian family.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12511408","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12893758","id":"PMC_12893758","title":"Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12893758","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31201813","id":"PMC_31201813","title":"SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.","date":"2019","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/31201813","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23129316","id":"PMC_23129316","title":"Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: a meta-analysis of 15,055 subjects.","date":"2012","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/23129316","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31576477","id":"PMC_31576477","title":"FGB and FGG derived from plasma exosomes as potential biomarkers to distinguish benign from malignant pulmonary nodules.","date":"2019","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31576477","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33322159","id":"PMC_33322159","title":"A Novel Nonsense Mutation in FGB (c.1421G>A; p.Trp474Ter) in the Beta Chain of Fibrinogen Causing Hypofibrinogenemia with Bleeding Phenotype.","date":"2020","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/33322159","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24560896","id":"PMC_24560896","title":"FGB mutations leading to congenital quantitative fibrinogen deficiencies: an update and report of four novel mutations.","date":"2014","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/24560896","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24352576","id":"PMC_24352576","title":"Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia.","date":"2013","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/24352576","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28306188","id":"PMC_28306188","title":"Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia.","date":"2017","source":"Haemophilia : the official journal of the World Federation of Hemophilia","url":"https://pubmed.ncbi.nlm.nih.gov/28306188","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17115186","id":"PMC_17115186","title":"TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17115186","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20580695","id":"PMC_20580695","title":"In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A>G causing abnormal RNA splicing.","date":"2010","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20580695","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16697386","id":"PMC_16697386","title":"Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 G/A polymorphism.","date":"2006","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/16697386","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35054908","id":"PMC_35054908","title":"Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35054908","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35469231","id":"PMC_35469231","title":"miR-139-5p Suppresses Proliferation and Angiogenesis of Intracranial Aneurysm via FGB.","date":"2022","source":"Journal of healthcare engineering","url":"https://pubmed.ncbi.nlm.nih.gov/35469231","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36438895","id":"PMC_36438895","title":"miR-877-5p Inhibits Epithelial Mesenchymal Transformation of Breast Cancer Cells by Targeting FGB.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/36438895","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22576285","id":"PMC_22576285","title":"Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes.","date":"2012","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/22576285","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37953225","id":"PMC_37953225","title":"Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression.","date":"2023","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/37953225","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21301788","id":"PMC_21301788","title":"A novel missense mutation in the FGB g. 3354 T>A (p. Y41N), fibrinogen Caracas VIII.","date":"2011","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/21301788","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32871307","id":"PMC_32871307","title":"Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative.","date":"2020","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/32871307","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23266225","id":"PMC_23266225","title":"A novel mutation in the FGB: c.1105C>T turns the codon for amino acid Bβ Q339 into a stop codon causing hypofibrinogenemia.","date":"2012","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23266225","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27812779","id":"PMC_27812779","title":"A novel mutation in exon 2 of FGB caused by c.221G>T † substitution, predicting the replacement of the native Arginine at position 74 with a Leucine (p.Arg74Leu † ) in a proband from a Kurdish family with dysfibrinogenaemia and familial venous and arterial thrombosis.","date":"2017","source":"Journal of thrombosis and thrombolysis","url":"https://pubmed.ncbi.nlm.nih.gov/27812779","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31259773","id":"PMC_31259773","title":"Phenotypic and genetic analysis of hypofibrinogenemia because of a novel missense mutation in the FGB: Leu121Arg.","date":"2019","source":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","url":"https://pubmed.ncbi.nlm.nih.gov/31259773","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25867317","id":"PMC_25867317","title":"Association between the FGB gene polymorphism and ischemic stroke: a meta-analysis.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25867317","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15300640","id":"PMC_15300640","title":"[Relationship between fibrinogen B beta gene FGB -455G/A polymorphism and atherosclerotic cerebral infarction].","date":"2004","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15300640","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33245842","id":"PMC_33245842","title":"Afibrinogenemia caused by a novel homozygous missense mutation, FGB p.Cys241Tyr, in a male patient with recurrent intracranial bleeding: case report and review of literature.","date":"2020","source":"Haemophilia : the official journal of the World Federation of Hemophilia","url":"https://pubmed.ncbi.nlm.nih.gov/33245842","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24720800","id":"PMC_24720800","title":"FGB gene - 148C>T polymorphism is associated with increased risk of ischemic stroke in a Chinese population: a meta-analysis based on 18 case-control studies.","date":"2014","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/24720800","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27824214","id":"PMC_27824214","title":"A novel missense mutation in the FGB gene (p.Gly302Arg) leading to afibrinogenemia. Predicted structure and function consequences.","date":"2016","source":"Hamostaseologie","url":"https://pubmed.ncbi.nlm.nih.gov/27824214","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32289806","id":"PMC_32289806","title":"Genetic Analysis of Afibrinogenemia and Hypofibrinogenemia: Novel Mutations in the FGB Gene in the Turkish Population.","date":"2020","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/32289806","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40774334","id":"PMC_40774334","title":"Recurrent Venous Thrombosis in a Hypofibrinogenemic Patient Despite a Heterozygous Deletion of the Fibrinogen Gene Cluster and Hemizygous FGB p.Pro265Leu Variant Mimicking a Homozygous Genotype.","date":"2025","source":"Hamostaseologie","url":"https://pubmed.ncbi.nlm.nih.gov/40774334","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32228225","id":"PMC_32228225","title":"Congenital fibrinogen disorder caused by digenic mutations of the FGA and FGB genes.","date":"2020","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/32228225","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15575509","id":"PMC_15575509","title":"[Association of polymorphic marker G(-455)A of gene FGB with coronary artery disease].","date":"2004","source":"Genetika","url":"https://pubmed.ncbi.nlm.nih.gov/15575509","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41090172","id":"PMC_41090172","title":"Quantitative proteomic and glycoproteomic analysis identifies CLCA1, FBN1, and FGB as potential biomarkers for ulcerative colitis.","date":"2025","source":"RSC advances","url":"https://pubmed.ncbi.nlm.nih.gov/41090172","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38669223","id":"PMC_38669223","title":"Identification of the FGB gene polymorphism and analysis of its association with fat deposition traits in Hu sheep.","date":"2024","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38669223","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33804389","id":"PMC_33804389","title":"Congenital Hypofibrinogenemia in a Neonate with a Novel Mutation in the FGB Gene.","date":"2021","source":"Pediatric reports","url":"https://pubmed.ncbi.nlm.nih.gov/33804389","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40506718","id":"PMC_40506718","title":"A heterozygous nonsense mutation in the FGB gene (c.1299G > A) causes congenital fibrinogen disorder across four consecutive generations.","date":"2025","source":"Thrombosis journal","url":"https://pubmed.ncbi.nlm.nih.gov/40506718","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34523592","id":"PMC_34523592","title":"Polymorphisms of F2 (G20210A), F5 (G1691A), F 7 (G10976A), F 13(G13T), FGB, ITGA2, ITGB3, PAI-I genes and its association with thrombotic complications in patients suffering from Takayasu aortoarteritis of Urals population.","date":"2021","source":"Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir","url":"https://pubmed.ncbi.nlm.nih.gov/34523592","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35773760","id":"PMC_35773760","title":"[Analysis of two pedigrees affected with inherited dysfibrinogenemia due to a novel c.1115 T>A variant of the FGB gene].","date":"2022","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35773760","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24103871","id":"PMC_24103871","title":"[Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].","date":"2013","source":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","url":"https://pubmed.ncbi.nlm.nih.gov/24103871","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40573382","id":"PMC_40573382","title":"Antiviral Intervention of COVID-19: Linkage of Disease Severity with Genetic Markers FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760).","date":"2025","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/40573382","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41233956","id":"PMC_41233956","title":"Congenital hypofibrinogenemia with bleeding risk: mutations in the FGA, FGB, and FGG genes.","date":"2026","source":"Laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41233956","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20873219","id":"PMC_20873219","title":"[Polymorphic markers G(-455)A of gene FGB and C(-1654)T of gene PROC and genetic predisposition to unfavorable outcomes patients undergoing acute coronary syndrome].","date":"2010","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/20873219","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.06.08.658502","title":"Primitive Hepatoblasts Driving Early Liver Development","date":"2025-06-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.08.658502","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.09.25323497","title":"Pan-Omics Fusion and Machine Learning Unveil Congenital Tooth Agenesis-Ecto-mesodermal Diseases Link and Biomarker Discovery","date":"2025-03-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.09.25323497","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.18.638886","title":"Chronic sleep curtailment expediates brain aging by activating the complement and coagulation cascades in mice","date":"2025-02-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.18.638886","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10391209","id":"PMC_10391209","title":"Characterization of single-nucleotide polymorphisms in coding regions of human genes.","date":"1999","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10391209","citation_count":1381,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14718574","id":"PMC_14718574","title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","date":"2004","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/14718574","citation_count":658,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6383194","id":"PMC_6383194","title":"Fibrinogen and fibrin.","date":"1984","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6383194","citation_count":600,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12665801","id":"PMC_12665801","title":"Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.","date":"2003","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/12665801","citation_count":485,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889549","id":"PMC_8889549","title":"Generation and analysis of 280,000 human expressed sequence tags.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889549","citation_count":376,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17643375","id":"PMC_17643375","title":"Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17643375","citation_count":367,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9333233","id":"PMC_9333233","title":"Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.","date":"1997","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9333233","citation_count":360,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16335952","id":"PMC_16335952","title":"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.","date":"2005","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16335952","citation_count":350,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8100742","id":"PMC_8100742","title":"Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8100742","citation_count":315,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7356959","id":"PMC_7356959","title":"Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences.","date":"1980","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7356959","citation_count":294,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16581250","id":"PMC_16581250","title":"p130Cas: a versatile scaffold in signaling networks.","date":"2006","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16581250","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19296670","id":"PMC_19296670","title":"Crystal structure of human fibrinogen.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19296670","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"6575689","id":"PMC_6575689","title":"Covalent structure of fibrinogen.","date":"1983","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/6575689","citation_count":241,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8666148","id":"PMC_8666148","title":"Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro.","date":"1996","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/8666148","citation_count":225,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10467729","id":"PMC_10467729","title":"Fibrinogen.","date":"1999","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10467729","citation_count":223,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23852822","id":"PMC_23852822","title":"Congenital fibrinogen disorders: an update.","date":"2013","source":"Seminars in thrombosis and hemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/23852822","citation_count":218,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24769233","id":"PMC_24769233","title":"Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.","date":"2014","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/24769233","citation_count":218,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16144795","id":"PMC_16144795","title":"Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16144795","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25037231","id":"PMC_25037231","title":"Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.","date":"2014","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25037231","citation_count":203,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28675934","id":"PMC_28675934","title":"Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.","date":"2017","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/28675934","citation_count":185,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24138,"output_tokens":2479,"usd":0.0548},"stage2":{"model":"claude-opus-4-6","input_tokens":5851,"output_tokens":2157,"usd":0.12477},"total_usd":0.436187,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":36068,"output_tokens":4432,"usd":0.087342},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8335,"output_tokens":2847,"usd":0.169275}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"The FGB nonsense mutation W467X (Trp467Stop) produces a truncated Bβ chain that prevents fibrinogen secretion into culture media when the mutant FGB cDNA is co-expressed with wild-type FGA and FGG cDNAs, establishing that the Bβ chain is required for fibrinogen assembly and secretion.\",\n      \"method\": \"Co-expression of mutant and wild-type fibrinogen chains in cell culture with measurement of secreted protein\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct recombinant expression assay with functional secretion readout, replicated across multiple FGB mutation studies\",\n      \"pmids\": [\"12511408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The FGB missense mutation G444S allows fibrinogen hexamer assembly but completely blocks secretion into the culture medium, demonstrating that this conserved C-terminal Bβ residue is specifically required for the secretion step rather than assembly.\",\n      \"method\": \"Co-expression of mutant FGB G444S cDNA with wild-type FGA and FGG cDNAs; measurement of secreted vs. intracellular fibrinogen\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — recombinant expression with functional separation of assembly vs. secretion, clear mechanistic conclusion\",\n      \"pmids\": [\"12893758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A deep intronic mutation (FGB c.115-600A>G) in intron 1 creates a consensus heptad motif that recruits the splicing factor SF2/ASF, causing inclusion of a 50-bp cryptic exon and producing an aberrant mRNA that would truncate the Bβ chain and prevent fibrinogen synthesis. Antisense morpholino oligonucleotides (PMOs) targeting the cryptic exon restored normal splicing (~50% at 2 µM, ~90% at 10 µM).\",\n      \"method\": \"Splicing reporter assays in transfected cells, site-directed mutagenesis of the ESE motif, antisense PMO treatment with RT-PCR quantification of normal vs. aberrant mRNA\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods: mutagenesis of ESE abolished aberrant splicing, PMO dose-response confirmed the SF2/ASF-dependent mechanism\",\n      \"pmids\": [\"18853456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"An FGB IVS6 deletion of 4 nucleotides (ΔT/G) causes aberrant mRNA splicing that retains both introns 6 and 7, generating a non-productive transcript that is likely degraded before translation, thereby reducing plasma fibrinogen levels (hypofibrinogenemia).\",\n      \"method\": \"Minigene cloning into expression vectors, transfection into CHO cells, RT-PCR with sequencing of aberrant mRNA products\",\n      \"journal\": \"Clinica chimica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — minigene splicing assay in CHO cells with direct sequencing; single study\",\n      \"pmids\": [\"20580695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A novel homozygous GTTT insertion frameshift mutation in FGB exon 2 causes afibrinogenemia by impairing intracellular fibrinogen assembly and preventing secretion; abnormal high-molecular-weight fibrinogen molecules were detected in transfected COS-7 cell lysates but no fibrinogen was detected in culture media, while ELISA showed equivalent intracellular protein levels.\",\n      \"method\": \"Western blot and ELISA of transfected COS-7 cell lysates and culture media; polymerization curve analysis of patient plasma\",\n      \"journal\": \"Zhonghua xue ye xue za zhi\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — recombinant expression with both Western blot and ELISA distinguishing intracellular assembly defect from secretion block\",\n      \"pmids\": [\"24103871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The Bβ Y41N substitution (fibrinogen Caracas VIII) at the amino-terminal end of the Bβ chain impairs fibrin polymerization kinetics and drastically alters clot structure (thicker fibers, larger pores, increased permeability, lower storage modulus), and reduces interaction of fibrin with endothelial cells, demonstrating that this region of the Bβ chain is critical for normal polymerization and clot architecture.\",\n      \"method\": \"Plasma permeation assay, scanning electron microscopy, viscoelastic/rheology measurements, confocal laser microscopy of fibrin-endothelial cell interaction\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional assays on patient-derived fibrinogen; single patient/mutation study\",\n      \"pmids\": [\"21301788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIRT1 represses FGB expression by deacetylating STAT3, leading to STAT3 destabilization and degradation; since STAT3 is a transcriptional activator of FGB, this SIRT1–STAT3–FGB axis controls FGB-dependent RCC cell proliferation in vitro and in vivo.\",\n      \"method\": \"Luciferase reporter assay confirming FGB as STAT3 target; co-immunoprecipitation of SIRT1-STAT3 complex; SIRT1 overexpression/knockdown with Western blot; in vitro and in vivo (xenograft) proliferation assays with rescue by FGB overexpression\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, reporter assay, and rescue experiment; single lab study\",\n      \"pmids\": [\"31201813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The FGB missense mutation Bβ Y416C alters fibrin polymerization (decreased maximal absorbance), changes fibrin fiber thickness and density by scanning electron microscopy, and modifies plasmin-induced fibrin degradation kinetics, indicating that residue Y416 in the Bβ chain contributes to normal fibrin network formation and susceptibility to fibrinolysis.\",\n      \"method\": \"Fibrin polymerization turbidity assay, scanning electron microscopy, reverse-phase HPLC for fibrinopeptide cleavage, plasmin-induced degradation assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays on patient fibrinogen; single lab\",\n      \"pmids\": [\"35054908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The FGB missense mutation Bβ A68S impairs fibrinopeptide B (FpB) release as measured by reverse-phase HPLC, demonstrating that residue A68 in the Bβ N-terminal region is required for normal thrombin cleavage of FpB.\",\n      \"method\": \"Reverse-phase HPLC quantification of fibrinopeptide B cleavage kinetics from patient fibrinogen\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct biochemical assay on patient-derived protein; single study\",\n      \"pmids\": [\"35054908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The FGB compound heterozygous deletion (35-bp intronic deletion near exon 7/8 boundary) generates two aberrant mRNA splicing products leading to nonsense-mediated mRNA decay and consequent hypofibrinogenemia, while the co-inherited Bβ N170K missense mutation (on the other allele) is secreted normally but causes dysfibrinogenemia through delayed lateral aggregation.\",\n      \"method\": \"Minigene transfection into CHO cells with RT-PCR for aberrant mRNA identification; recombinant Bβ N170K fibrinogen secretion assay; purified patient plasma fibrinogen polymerization analysis\",\n      \"journal\": \"Thrombosis research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — minigene splicing assay plus recombinant protein secretion and functional polymerization assay; single lab\",\n      \"pmids\": [\"32871307\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGB encodes the fibrinogen Bβ chain, which is the rate-limiting subunit for hepatic fibrinogen hexamer assembly and secretion; the Bβ chain's N-terminal region governs thrombin-mediated fibrinopeptide B release and fibrin polymerization initiation, while its conserved C-terminal β-nodule domain is essential for proper folding and secretion of the assembled hexamer, and FGB transcription is regulated by the SIRT1–STAT3 deacetylation axis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1984,\n      \"finding\": \"Fibrinogen is a hexameric glycoprotein composed of pairs of three chains (Aα, Bβ, and γ); thrombin cleaves fibrinogen to form insoluble fibrin polymer, establishing the fundamental mechanism of fibrin clot formation.\",\n      \"method\": \"Biochemical characterization, covalent structure analysis\",\n      \"journal\": \"Annual review of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational biochemical reconstitution and structural work, replicated across decades\",\n      \"pmids\": [\"6383194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1980,\n      \"finding\": \"Synthetic peptides corresponding to the N-terminal sequences released from fibrinogen by thrombin (fibrinopeptides) bind to fibrinogen and prevent fibrin polymerization, defining the knob-hole polymerization mechanism involving the β-chain N-terminus.\",\n      \"method\": \"In vitro peptide binding assay, inhibition of fibrin polymerization\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro reconstitution with defined peptides, foundational mechanistic study\",\n      \"pmids\": [\"7356959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1983,\n      \"finding\": \"Complete covalent structure of fibrinogen determined, including the primary sequence of the Bβ chain encoded by FGB, establishing the disulfide bonding pattern and chain organization of the hexameric molecule.\",\n      \"method\": \"Protein sequencing, covalent structure determination\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct protein sequencing and structural determination, foundational study\",\n      \"pmids\": [\"6575689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Fibrinogen mediates leukocyte adhesion to vascular endothelium through binding to ICAM-1 on endothelial cells, bridging leukocytes and endothelial cells in an ICAM-1-dependent adhesion pathway.\",\n      \"method\": \"Affinity chromatography purification, genetically engineered transfectants, direct binding studies to recombinant ICAM-1, cell adhesion assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including affinity purification, recombinant protein binding, and functional adhesion assays in a single study\",\n      \"pmids\": [\"8100742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Crystal structure of fragment D from human fibrinogen determined at 2.9 Å resolution, revealing a coiled-coil region and two homologous globular domains (β and γ nodules) oriented at ~130° to each other; the double-D structure from crosslinked fibrin solved with a Gly-Pro-Arg-Pro peptide ligand defines the donor polymerization site.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional peptide ligand validation\",\n      \"pmids\": [\"9333233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Hyperglycemia stimulates IL-6 and TNF-α production by human peripheral blood monocytes, and conditioned media from these monocytes increases β-fibrinogen (FGB) mRNA levels in HepG2 hepatocytes, establishing a TNF→IL-6→FGB transcriptional induction axis.\",\n      \"method\": \"RT-PCR, ELISA, conditioned medium transfer to HepG2 cells, anti-TNF antibody blockade\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (RT-PCR, ELISA, antibody blocking) in a single lab establishing the cytokine-FGB induction pathway\",\n      \"pmids\": [\"8666148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of intact human fibrinogen determined at ~3.3 Å resolution, revealing the full hexameric architecture including the coiled-coil regions, D and E nodules, the β-chain carbohydrate groups with 11 sugar residues, and a novel antiparallel arrangement of β chains.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure of intact human fibrinogen\",\n      \"pmids\": [\"19296670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A deep intronic point mutation in FGB (c.115-600A>G) creates a consensus heptad motif recognized by SF2/ASF splicing factor, causing inclusion of a 50-bp cryptic exon and truncation of the Bβ chain, preventing fibrinogen synthesis; antisense morpholino oligonucleotides blocking the protein-RNA interaction restored normal splicing (~90% at 10 µM).\",\n      \"method\": \"Minigene splicing assay, site-directed mutagenesis of enhancer motif, antisense oligonucleotide treatment in transfected cells, RT-PCR\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution with mutagenesis and functional rescue by antisense oligonucleotides, multiple orthogonal methods\",\n      \"pmids\": [\"18853456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Expression of the FGB nonsense mutant W467X in combination with wild-type FGA and FGG showed that fibrinogen molecules containing the truncated Bβ chain are not secreted, confirming that the Bβ chain C-terminal region is required for fibrinogen secretion.\",\n      \"method\": \"Recombinant expression of mutant FGB cDNA with wild-type FGA and FGG in cell lines, secretion assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional expression system demonstrating secretion defect, single lab\",\n      \"pmids\": [\"12511408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A missense mutation in FGB (G444S) allows fibrinogen chain assembly but prevents secretion, demonstrating that the C-terminal β-nodule region is critical for intracellular fibrinogen assembly and secretion rather than chain synthesis.\",\n      \"method\": \"Recombinant co-expression of mutant FGB with wild-type FGA and FGG, secretion assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional expression dissecting assembly vs. secretion steps, single lab\",\n      \"pmids\": [\"12893758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A missense mutation at FGB Bβ41 (Tyr→Asn, fibrinogen Caracas VIII) impairs the fibrin polymerization process—prolonging lag time, altering clot structure (thicker fibers, larger pores, reduced viscoelasticity), and reducing fibrin interaction with endothelial cells—demonstrating the functional importance of the amino-terminal end of the β chain in polymerization and clot organization.\",\n      \"method\": \"Plasma polymerization assay, permeation studies, scanning electron microscopy, confocal laser microscopy, viscoelastic property measurement\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple functional assays on patient plasma with defined mutation, single lab\",\n      \"pmids\": [\"21301788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A novel frameshift insertion in FGB exon 2 (GTTT insertion between nucleotides 2833-2834) causes impaired intracellular fibrinogen assembly (abnormal high-molecular-weight molecules in cells) and prevents fibrinogen secretion, as shown by transfection of COS-7 cells with mutant constructs.\",\n      \"method\": \"Western blot, ELISA of cell lysates and culture media, transfection of COS-7 cells with wild-type and mutant fibrinogen constructs\",\n      \"journal\": \"Zhonghua xue ye xue za zhi\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based functional reconstitution demonstrating assembly and secretion defect, single lab\",\n      \"pmids\": [\"24103871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"An FGB IVS6 deletion of 4 nucleotides causes aberrant mRNA splicing with inclusion of introns 6 and 7, demonstrated by RT-PCR of minigene constructs transfected in CHO cells; the aberrant mRNA is predicted to undergo nonsense-mediated decay, causing hypofibrinogenemia.\",\n      \"method\": \"Minigene transfection in CHO cells, RT-PCR, agarose gel electrophoresis, nucleotide sequencing\",\n      \"journal\": \"Clinica chimica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based minigene splicing assay with sequencing confirmation, single lab\",\n      \"pmids\": [\"20580695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SIRT1 represses FGB expression in renal cell carcinoma by deacetylating STAT3, leading to STAT3 destabilization and degradation; STAT3 was identified as a direct transcriptional activator of FGB by luciferase reporter assay, and FGB overexpression rescued the anti-proliferative effect of SIRT1, establishing a SIRT1→STAT3→FGB axis.\",\n      \"method\": \"Luciferase reporter assay, co-immunoprecipitation, Western blot, stable transfection, in vitro and in vivo proliferation assays\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (luciferase, Co-IP, rescue experiment), single lab\",\n      \"pmids\": [\"31201813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A heterozygous nonsense mutation FGB Bβ p.Trp474Ter results in truncated Bβ chains predicted to be retained inside hepatocytes (not secreted), causing quantitative hypofibrinogenemia; turbidity analyses showed reduced fibrin polymerization and altered fibrin fiber thickness consistent with reduced fibrinogen concentration.\",\n      \"method\": \"Protein modelling, fibrin polymerization turbidity analysis, scanning electron microscopy, coagulation functional analysis\",\n      \"journal\": \"Biomedicines\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional assays and structural modelling, secretion inference from modelling rather than direct experiment\",\n      \"pmids\": [\"33322159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A compound heterozygous FGB 35-bp deletion causes aberrant splicing products leading to nonsense-mediated mRNA decay (quantitative defect), while the second allele carrying BβN170K produces fibrinogen that is secreted normally but causes delayed lateral aggregation in fibrin polymerization (qualitative defect), demonstrated by minigene assay and recombinant expression in CHO cells.\",\n      \"method\": \"Minigene transfection in CHO cells, RT-PCR, Western blot, recombinant variant fibrinogen expression, thrombin-catalyzed fibrin polymerization assay\",\n      \"journal\": \"Thrombosis research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (minigene, recombinant expression, functional polymerization assay) establishing both splicing and functional defects, single lab\",\n      \"pmids\": [\"32871307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Four FGB missense/nonsense variants (BβY416C, BβA68S, BβY345*, BβW403*) all alter fibrin polymerization (reduced maximal absorbance); BβA68S impairs fibrinopeptide B release; BβY416C and BβW403* alter plasmin-induced fibrin degradation kinetics; fiber morphology differs significantly across variants by scanning electron microscopy.\",\n      \"method\": \"Fibrin polymerization turbidity assay, reverse-phase HPLC fibrinopeptide cleavage assay, plasmin degradation assay, scanning electron microscopy, homology modelling\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal functional assays per variant, single lab\",\n      \"pmids\": [\"35054908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-139-5p directly targets FGB mRNA; overexpression of miR-139-5p or silencing of FGB inhibits human brain microvascular endothelial cell (HBMEC) proliferation and tube formation and suppresses α-SMA and CXCR4 levels; rescue experiment confirmed miR-139-5p acts through FGB to regulate angiogenesis.\",\n      \"method\": \"miRNA target validation, shRNA knockdown, cell proliferation assay, tube formation assay, Western blot, rescue experiment\",\n      \"journal\": \"Journal of healthcare engineering\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional cellular assays with rescue, but single lab and target validation method not explicitly described as luciferase\",\n      \"pmids\": [\"35469231\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-877-5p directly regulates FGB; FGB silencing inhibits breast cancer cell proliferation and invasion, reduces tumor growth in vivo, and reverses epithelial-mesenchymal transition (reducing N-cadherin and vimentin while increasing E-cadherin).\",\n      \"method\": \"RT-qPCR, immunohistochemistry, CCK-8 proliferation assay, transwell invasion assay, flow cytometry, Western blot, xenograft tumor model\",\n      \"journal\": \"Disease markers\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — functional knockdown with phenotypic readout but no direct molecular mechanism of FGB action defined, single lab\",\n      \"pmids\": [\"36438895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FGG haplotype H2 homozygosity reduces fibrinogen γ' levels and increases deep venous thrombosis risk ~2.4-fold; fibrinogen γ' contains a unique high-affinity non-substrate thrombin-binding site critical for antithrombin activity during fibrin formation (antithrombin 1), linking fibrinogen γ-chain variants to thrombin regulation.\",\n      \"method\": \"Haplotype-tagging SNP analysis, fibrinogen γ' level measurement, multivariate analysis in a population-based case-control study (Leiden Thrombophilia Study)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — large population study with functional fibrinogen measurement; the antithrombin 1 mechanism is biochemically established in earlier literature cited herein\",\n      \"pmids\": [\"16144795\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGB encodes the fibrinogen Bβ chain, which is the rate-limiting chain in hepatic assembly of the hexameric fibrinogen molecule (Aα₂Bβ₂γ₂); thrombin cleaves fibrinopeptide B from the Bβ N-terminus to expose polymerization knobs that drive fibrin polymer formation, the Bβ C-terminal β-nodule domain is essential for intracellular assembly and secretion of fibrinogen (missense and nonsense mutations in this domain impair secretion without preventing chain synthesis), FGB transcription is regulated by a SIRT1→STAT3 deacetylation axis, and the γ' isoform of fibrinogen provides a high-affinity non-substrate thrombin-binding site that mediates antithrombin 1 activity, while fibrinogen as a whole bridges leukocytes to endothelium via ICAM-1.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FGB encodes the fibrinogen Bβ chain, an essential subunit of the fibrinogen hexamer whose integrity governs both intracellular assembly/secretion of the molecule and the polymerization properties of the resulting fibrin clot. The Bβ chain C-terminal domain is required for fibrinogen secretion, as demonstrated by truncating and missense mutations (e.g., W467X, G444S) that permit intracellular hexamer formation but abolish export [PMID:12511408, PMID:12893758]. The Bβ N-terminal region controls thrombin-mediated fibrinopeptide B release and fibrin polymerization; mutations such as Bβ A68S impair thrombin cleavage, while Bβ Y41N drastically alters clot architecture and fiber morphology [PMID:35054908, PMID:21301788]. FGB transcription is positively regulated by STAT3, and the SIRT1 deacetylase represses FGB expression by promoting STAT3 degradation [PMID:31201813].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that the Bβ C-terminal domain is indispensable for fibrinogen secretion resolved whether assembly and export are separable steps: the W467X truncation blocked both, whereas G444S allowed assembly but completely prevented secretion.\",\n      \"evidence\": \"Recombinant co-expression of mutant FGB with wild-type FGA/FGG in cell culture with secretion and intracellular protein measurement\",\n      \"pmids\": [\"12511408\", \"12893758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural basis explaining why G444S permits assembly but blocks secretion\",\n        \"ER quality-control pathway responsible for retaining misfolded hexamers not identified\",\n        \"Whether other C-terminal Bβ residues have similarly dissociable effects is untested\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that deep intronic FGB mutations create cryptic exons via SF2/ASF recruitment explained a previously unrecognized class of afibrinogenemia alleles and showed these splicing defects are correctable by antisense morpholinos.\",\n      \"evidence\": \"Splicing reporter assays, ESE mutagenesis, and dose-response PMO treatment with RT-PCR in transfected cells\",\n      \"pmids\": [\"18853456\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo efficacy of PMO-based correction not demonstrated\",\n        \"Whether other deep intronic FGB variants similarly recruit SF2/ASF is unknown\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of additional splice-site mutations (IVS6 ΔT/G, exon 7/8 boundary deletion) causing intron retention and nonsense-mediated decay expanded the spectrum of FGB regulatory defects underlying hypofibrinogenemia.\",\n      \"evidence\": \"Minigene splicing assays in CHO cells with RT-PCR sequencing of aberrant products\",\n      \"pmids\": [\"20580695\", \"32871307\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Quantitative contribution of NMD versus translational readthrough not measured\",\n        \"Studies performed in heterologous CHO cells; hepatocyte-specific splicing context not tested\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Characterization of Bβ Y41N (Caracas VIII) revealed that the Bβ N-terminal region governs fibrin polymerization kinetics, clot fiber architecture, and fibrin–endothelial cell interaction, extending the chain's function beyond thrombin substrate.\",\n      \"evidence\": \"Permeation, SEM, rheology, and confocal microscopy on patient-derived fibrinogen\",\n      \"pmids\": [\"21301788\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single patient study; recombinant reconstitution not performed\",\n        \"Molecular mechanism by which Y41N alters lateral aggregation not resolved\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"An exon 2 frameshift mutation confirmed that early Bβ chain truncation produces abnormal high-molecular-weight aggregates retained intracellularly, reinforcing the Bβ chain's role in proper hexamer assembly.\",\n      \"evidence\": \"Western blot and ELISA of COS-7 cell lysates versus culture media after recombinant expression\",\n      \"pmids\": [\"24103871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Nature of the high-molecular-weight aggregates (misfolded intermediates vs. aberrant polymers) not characterized\",\n        \"ER stress response to accumulated aggregates not examined\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery of the SIRT1–STAT3–FGB transcriptional axis established the first defined signaling pathway controlling FGB expression, showing SIRT1 deacetylates and destabilizes STAT3, thereby reducing FGB transcription.\",\n      \"evidence\": \"Co-IP of SIRT1-STAT3, luciferase reporter for FGB promoter, SIRT1 overexpression/knockdown, and xenograft rescue with FGB in RCC cells\",\n      \"pmids\": [\"31201813\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relevance of this axis in hepatocytes (the primary fibrinogen-producing cell) not shown\",\n        \"Whether other STAT3-targeting deacetylases similarly regulate FGB is unknown\",\n        \"Single-lab finding; independent replication not available\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Biochemical dissection of Bβ A68S and Bβ Y416C mutations pinpointed specific residues governing fibrinopeptide B release (A68) and fibrin network density/fibrinolysis susceptibility (Y416), refining the structure–function map of the Bβ chain.\",\n      \"evidence\": \"RP-HPLC fibrinopeptide cleavage kinetics, turbidity polymerization assays, SEM, and plasmin degradation assays on patient fibrinogen\",\n      \"pmids\": [\"35054908\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Recombinant validation of each mutation in isolation not performed\",\n        \"Structural modeling of how A68S alters thrombin docking not available\",\n        \"Effect of Bβ Y416C on in vivo clot stability not tested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A comprehensive structure–function map integrating Bβ chain residues required for assembly, secretion, thrombin cleavage, polymerization, and fibrinolysis has not been established, and the hepatocyte-specific transcriptional regulation of FGB remains incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of the full Bβ chain in the context of the hexamer with mutationally validated functional sites\",\n        \"Hepatocyte-specific regulators of FGB transcription beyond IL-6/STAT3 not mapped\",\n        \"Mechanism by which ER quality control distinguishes assembly-competent from secretion-incompetent hexamers is unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 1, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 9]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [5, 7, 8]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"complexes\": [\n      \"fibrinogen hexamer (α2β2γ2)\"\n    ],\n    \"partners\": [\n      \"FGA\",\n      \"FGG\",\n      \"STAT3\",\n      \"SIRT1\",\n      \"SRSF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"FGB encodes the fibrinogen Bβ chain, one of three polypeptide chains that assemble into the hexameric fibrinogen molecule (Aα₂Bβ₂γ₂) essential for blood coagulation and fibrin clot formation [PMID:6383194, PMID:6575689]. Thrombin cleavage of fibrinopeptide B from the Bβ N-terminus exposes polymerization knobs that drive fibrin lateral aggregation through a knob-hole mechanism, and mutations at this site (e.g., Bβ Tyr41Asn, Bβ A68S) impair polymerization kinetics and clot architecture [PMID:7356959, PMID:21301788, PMID:35054908]. The C-terminal β-nodule is required for intracellular fibrinogen assembly and secretion: nonsense and missense mutations in this domain (W467X, G444S, W474X) permit chain synthesis but block secretion, causing congenital hypo- or afibrinogenemia [PMID:12511408, PMID:12893758]. Beyond hemostasis, fibrinogen bridges leukocytes to vascular endothelium through ICAM-1 binding, and FGB transcription is regulated by an IL-6/STAT3 axis that is modulated by SIRT1-mediated STAT3 deacetylation [PMID:8100742, PMID:8666148, PMID:31201813].\",\n  \"teleology\": [\n    {\n      \"year\": 1980,\n      \"claim\": \"Defining the molecular mechanism of fibrin polymerization: synthetic peptides mimicking thrombin-released fibrinopeptides bound fibrinogen and blocked polymerization, establishing that the Bβ N-terminus exposes a polymerization knob upon cleavage.\",\n      \"evidence\": \"In vitro peptide binding and polymerization inhibition assays\",\n      \"pmids\": [\"7356959\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis of knob-hole interaction was not yet resolved\",\n        \"Relative contribution of fibrinopeptide A vs. B cleavage to polymerization kinetics was unclear\"\n      ]\n    },\n    {\n      \"year\": 1984,\n      \"claim\": \"The complete covalent structure and chain organization of fibrinogen (Aα₂Bβ₂γ₂) were established, defining the hexameric architecture and disulfide bonding pattern that frames all subsequent structure–function studies of the Bβ chain.\",\n      \"evidence\": \"Protein sequencing and biochemical characterization\",\n      \"pmids\": [\"6383194\", \"6575689\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Three-dimensional atomic structure was still unknown\",\n        \"Chain-specific contributions to assembly and secretion were not dissected\"\n      ]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Fibrinogen was shown to function beyond coagulation as an adhesion bridge between leukocytes and endothelial ICAM-1, establishing a non-hemostatic role in vascular inflammation.\",\n      \"evidence\": \"Affinity chromatography, recombinant ICAM-1 binding studies, and cell adhesion assays using genetically engineered transfectants\",\n      \"pmids\": [\"8100742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which fibrinogen chain or domain directly contacts ICAM-1 was not mapped\",\n        \"In vivo relevance of fibrinogen-ICAM-1 bridging in inflammatory disease models was not tested\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Hyperglycemia-induced monocyte cytokine release was linked to hepatic FGB transcriptional upregulation via a TNF→IL-6 axis, explaining elevated fibrinogen in diabetic patients.\",\n      \"evidence\": \"RT-PCR of FGB mRNA in HepG2 cells treated with conditioned media, ELISA, anti-TNF antibody blocking\",\n      \"pmids\": [\"8666148\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct promoter elements mediating IL-6 responsiveness of FGB were not mapped in this study\",\n        \"Whether this pathway operates identically in primary hepatocytes was not shown\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The crystal structure of fibrinogen fragment D revealed the three-dimensional architecture of the β- and γ-nodules and defined the structural basis of knob-hole polymerization at atomic resolution.\",\n      \"evidence\": \"X-ray crystallography at 2.9 Å with GPRP peptide ligand\",\n      \"pmids\": [\"9333233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full-length fibrinogen structure including the central E nodule was still missing\",\n        \"Structural consequences of disease-causing Bβ mutations were not modeled\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Reconstitution experiments with truncated and missense Bβ variants (W467X, G444S) demonstrated that the C-terminal β-nodule is dispensable for chain synthesis but essential for fibrinogen secretion, separating the assembly and secretion steps mechanistically.\",\n      \"evidence\": \"Recombinant co-expression of mutant FGB with wild-type FGA/FGG in mammalian cell lines, secretion assays\",\n      \"pmids\": [\"12511408\", \"12893758\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the secretion defect arises from ER quality control or Golgi-level retention was not resolved\",\n        \"Structural basis of why the β-nodule is required for secretion was not defined\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The full-length fibrinogen crystal structure completed the atomic picture of the hexamer, revealing a novel antiparallel Bβ chain arrangement and carbohydrate organization, while a deep intronic FGB mutation was shown to cause cryptic exon inclusion rescuable by antisense oligonucleotides.\",\n      \"evidence\": \"X-ray crystallography at ~3.3 Å (intact fibrinogen); minigene splicing assays with antisense morpholino rescue\",\n      \"pmids\": [\"19296670\", \"18853456\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Therapeutic applicability of antisense rescue in vivo was not tested\",\n        \"Dynamic conformational changes during polymerization were not captured\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A natural Bβ Tyr41Asn variant (Caracas VIII) prolonged polymerization lag time, altered clot fiber thickness and pore size, and reduced viscoelasticity, quantitatively demonstrating the functional importance of the Bβ N-terminal region in clot architecture.\",\n      \"evidence\": \"Patient plasma polymerization assays, permeation studies, scanning electron microscopy, viscoelastic measurements\",\n      \"pmids\": [\"21301788\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether altered clot structure translates to bleeding risk in vivo was not demonstrated\",\n        \"The precise structural interaction disrupted by Tyr41Asn was not defined at atomic resolution\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"STAT3 was identified as a direct transcriptional activator of FGB, and SIRT1-mediated deacetylation of STAT3 destabilizes it, repressing FGB expression — establishing an epigenetic regulatory axis for FGB transcription outside the classic acute-phase response.\",\n      \"evidence\": \"Luciferase reporter assay, co-immunoprecipitation, FGB overexpression rescue of SIRT1 anti-proliferative effect in renal carcinoma cells\",\n      \"pmids\": [\"31201813\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the SIRT1–STAT3–FGB axis operates in hepatocytes (the physiological source of fibrinogen) was not tested\",\n        \"Direct STAT3 binding to the FGB promoter was shown by reporter but not by ChIP\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Systematic functional characterization of multiple FGB missense and nonsense variants showed that individual mutations differentially affect fibrinopeptide B release, polymerization kinetics, fiber morphology, and plasmin-mediated fibrinolysis, revealing residue-specific contributions across distinct phases of clot formation and resolution.\",\n      \"evidence\": \"Turbidity polymerization assays, HPLC fibrinopeptide cleavage, plasmin degradation kinetics, scanning electron microscopy\",\n      \"pmids\": [\"35054908\", \"32871307\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Genotype–phenotype correlation with clinical bleeding severity is lacking for most variants\",\n        \"Structural modeling has not been validated by crystal structures of variant fibrinogens\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of β-nodule-dependent ER quality control during fibrinogen secretion, the in vivo contribution of the fibrinogen–ICAM-1 interaction to inflammatory disease, and whether the SIRT1–STAT3–FGB transcriptional axis operates in primary hepatocytes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural or cryo-EM data showing how the β-nodule is recognized by ER chaperones\",\n        \"No genetic model isolating fibrinogen-ICAM-1 binding from coagulation function in vivo\",\n        \"Comprehensive genotype–phenotype map for FGB variants and clinical outcomes is absent\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2, 6]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 4, 6]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [8, 9, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [0, 1, 4, 10, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [8, 9, 11]}\n    ],\n    \"complexes\": [\n      \"Fibrinogen (Aα₂Bβ₂γ₂ hexamer)\"\n    ],\n    \"partners\": [\n      \"FGA\",\n      \"FGG\",\n      \"ICAM1\",\n      \"STAT3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}